Modality.AI, Inc. was founded in 2018 by CEO David Suendermann-Oeft, PhD, and CTO David Pautler, PhD, experts in AI and signal processing. Modality has pioneered technology for assessing neurological and psychiatric conditions remotely or in clinical settings through AI-powered audio and visual measurements of patient conversations with their virtual agent Tina.

From Parkinson’s disease to schizophrenia and depression, Modality's multimodal platform, listed with the FDA as a Class II medical device, is being used by leading clinical institutions globally to diagnose, monitor, and expedite the care and treatment of patients.

Team Investors Testimonials Awards